APIXABAN FORMULATIONS

• 收藏
• 分享

专利权人:

Bristol-Myers Squibb Company;Pfizer Inc.

发明人:

Jatin Patel,Charles Frost,Jingpin Jia,Chandra Vemavarapu

申请号：

US15086447

公开号：

US20160243101A1

申请日:

2016.03.31

申请国别(地区):

US

年份:

2016

代理人:

摘要：

Compositions comprising crystalline apixaban particles having a D90 equal to or less than 89 μm, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to for the treatment and/or prophylaxis of thromboembolic disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/